New Jersey MedicaidMedicaid · Billing Codes · Provider Notice · NJMedium impact
Newsletter Vol. 13, No. 55
Act
by Aug 1, 2003
Effective date
Jan 1, 2003
Identified
Jun 20, 2026
Summary
New Jersey Medicaid and NJ FamilyCare updated the list of approved practitioner-administered drugs with three effective dates: (1) One new HCPCS code (Q4053 for Neulasta) added effective July 1, 2003; (2) Reimbursement rates changed for 11 existing drug codes effective January 1, 2003; (3) One code (C9119) deleted effective August 1, 2003 with replacement code Q4053. Billing teams must update fee schedules and code submissions accordingly.
Get alerts when payers change rules like this one
We check New Jersey Medicaid and other payers every day and email you when a change matches your specialty and state.
01Billing team must (1) immediately update fee schedules in billing system for the 11 drug codes with changed reimbursement rates (J0150, J0300, J0640, J0706, J1626, J1650, J1835, J2000, J2820, J9150, S0023) to reflect new maximum fee allowances; (2) add Q4053 (Neulasta per 1 mg, $491.67 max fee) to system effective July 1, 2003; (3) delete code C9119 and replace with Q4053 effective August 1, 2003; (4) instruct providers to enter the lower of average wholesale price (AWP) or acquisition cost in block 24F on CMS 1500 claim forms.
02Update billing software and provider documentation.
If missed: Failure to implement these changes will result in claim denials and payment delays for practitioner-administered drugs.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.